NEUROMOLECULAR MEDICINE SCIE
神经分子医学
1535-1084
Quarterly
No
NEUROMOL MED
47
UNITED STATES
http://link.springer.com/journal/12017
>12周，或约稿审稿时间
一般平均录用比例
3.9影响因子
神经科学小学科
86/314JIF RANK
2555总被引频次
1535-1084
Quarterly
No
NEUROMOL MED
47
UNITED STATES
http://link.springer.com/journal/12017
>12周，或约稿审稿时间
一般平均录用比例
3.9影响因子
神经科学小学科
86/314JIF RANK
2555总被引频次
月期刊平台服务过的文章录用时间为1-3个月，依据20年经验，经月期刊专家预审通过后的文章，投稿通过率100%以上！
由施普林格出版。ISSN: 1535 - 1084。马克·马特森(Mark Mattson)是《分子神经科学杂志》(Journal of Molecular Neuroscience, JMN)的联合编辑，现在与克里斯汀·范布罗克霍文(Christine van Broeckhoven)和约翰·哈代(John Hardy)合作，为神经疾病的分子遗传学、生物化学和细胞生物学开发了一个更专注的场所。神经分子医学(JMN的B部分)致力于在这些令人兴奋的研究领域发表高质量的原创研究和批判性评论。神经分子医学将包括分子遗传学、信号转导、可塑性和细胞死亡领域的基础研究，并将特别关注旨在将遗传异常与神经发病的细胞和分子机制连接起来的合成研究和综述。发表在NMM上的信息将为神经系统的分子医学的未来提供一个窗口。
https://www.editorialmanager.com/nemm/
Published by Springer. ISSN: 1535-1084.Mark Mattson has been coeditor of the Journal of Molecular Neuroscience (JMN) and is now, with Christine van Broeckhoven and John Hardy, developing a more focused venue for the molecular genetics, biochemistry and cell biology of neurological disorders. NeuroMolecular Medicine (Part B of JMN) is committed to publishing high quality original research and critical reviews in these exciting areas of research. NeuroMolecular Medicine will encompass basic research in the fields of molecular genetics, signal transduction, plasticity, and cell death, and will give special attention to synthetic research and reviews that aim to bridge genetic aberrancies with cellular and molecular mechanisms of neurological pathogenesis. The information published in NMM will provide a window into the future of molecular medicine for the nervous system.
